Nephrology clinical trials recruiting in Pennsylvania

36 recruiting nephrology trials match in Pennsylvania. Showing 20.

• Transforming Hemodialysis-Related Vascular Access EducationRecruiting

  N/A · University of Pennsylvania · Philadelphia, Pennsylvania

• A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)Recruiting

  Phase 3 · Boehringer Ingelheim · Indianapolis, Indiana

• An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney TransplantRecruiting

  N/A · Regeneron Pharmaceuticals · Philadelphia, Pennsylvania

• A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and ProteinuriaRecruiting

  Phase 3 · Bayer · Palo Alto, California

• Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF SystemRecruiting

  N/A · C. R. Bard · Butler, Pennsylvania

• Oral Iron in Children With Chronic Kidney DiseaseRecruiting

  Phase 4 · Weill Medical College of Cornell University · Philadelphia, Pennsylvania

• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRecruiting

  Phase 3 · AstraZeneca · Bridgeville, Pennsylvania

• A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.Recruiting

  Phase 2 · AstraZeneca · Media, Pennsylvania

• Ferric Citrate and Chronic Kidney Disease in ChildrenRecruiting

  Phase 2 · University of California, Los Angeles · Philadelphia, Pennsylvania

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Recruiting

  Phase 2 / Phase 3 · CSL Behring · Bethlehem, Pennsylvania

• Empagliflozin Treatment in Kidney Transplant RecipientsRecruiting

  Phase 4 · VA Office of Research and Development · Pittsburgh, Pennsylvania

• PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on HemodialysisRecruiting

  N/A · Merit Medical Systems, Inc. · Pittsburgh, Pennsylvania

• PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesRecruiting

  Phase 4 · Brigham and Women's Hospital · Danville, Pennsylvania

• Transformative Research in Diabetic NephropathyRecruiting

  N/A · University of Pennsylvania · Allentown, Pennsylvania

• Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal CenterRecruiting

  N/A · University of Michigan · Ann Arbor, Michigan

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)Recruiting

  Phase 3 · Boehringer Ingelheim · Philadelphia, Pennsylvania

• International (Pediatric) Peritoneal BiobankRecruiting

  N/A · Heidelberg University · Kansas City, Missouri

• Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA NephropathyRecruiting

  Phase 4 · Calliditas Therapeutics AB · Philadelphia, Pennsylvania

• A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)Recruiting

  Phase 2 · Akebia Therapeutics · Bridgeville, Pennsylvania

• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and ProteinuriaRecruiting

  Phase 3 · Bayer · Palo Alto, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.